News

More than 90% of dermatology clinicians surveyed by Leo Pharma say their patients with moderate to severe chronic hand eczema ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement and first Direct-to-Consumer (DTC) multichannel ...
A report released by MEXC, a leading global crypto exchange, indicates that airdrop campaigns account for approximately ...
This nourishing formula is ready to relieve your skin. Believe it or not, Black people can get sun burnt. As a Trinidadian ...
When she was finally diagnosed with hand dermatitis, she was fast-tracked for UVB red light therapy, but this only ...
Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.
Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...
AD is a growing market with an impressive pipeline of new products from current and future players in the field.
After her experience, the Yorkshire mum encourages parents to consider the products they use to wash their children’s ...
In the DELTA FORCE trial by Ana Maria Giménez-Arnau and colleagues, 11 delgocitinib cream was compared with the only systemic treatment approved for severe chronic hand eczema, oral alitretinoin, in a ...
While certain skin conditions such as acne can seem easy to diagnose from home, others can be a bit trickier, like eczema and ...